Aquestive Therapeutics, Inc. (NASDAQ:AQST) has 173 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Bratton Capital Management, L.P. | 31 Mar, 2026 | 9,810,958 | 0 | 0.00% | $40,715,476.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 7,509,071 | -266,331 | -3.43% | $31,162,644.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 7,426,471 | 1,176,471 | 18.82% | $30,819,855.00 |
| Federated Hermes, Inc. | 31 Mar, 2026 | 2,940,339 | 907,517 | 44.64% | $12,202,407.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 2,900,570 | 1,929,631 | 198.74% | $12,037,366.00 |
| State Street Corp | 31 Mar, 2026 | 2,546,191 | 83,413 | 3.39% | $10,566,693.00 |
| Samsara BioCapital, LLC | 31 Mar, 2026 | 2,500,000 | 0 | 0.00% | $10,375,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,408,191 | 40,099 | 1.69% | $9,996,351.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 2,405,050 | 1,197,459 | 99.16% | $9,980,958.00 |
| Sio Capital Management, LLC | 31 Mar, 2026 | 1,922,887 | 929,792 | 93.63% | $7,979,981.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,591,792 | -166,958 | -9.49% | $6,605,938.00 |
| Blue Owl Capital Holdings LP | 31 Mar, 2026 | 1,347,932 | 297,932 | 28.37% | $5,593,918.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 1,139,404 | 758,284 | 198.96% | $4,728,527.00 |
| Janney Montgomery Scott LLC | 31 Mar, 2026 | 1,089,110 | -4,100 | -0.38% | $4,520.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 31 Mar, 2026 | 1,082,680 | 62,888 | 6.17% | $4,493,124.00 |
| Wells Fargo & Company/Mn | 31 Mar, 2026 | 1,034,644 | -153,887 | -12.95% | $4,293,773.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 1,030,050 | 517,830 | 101.10% | $4,274,707.00 |
| WASATCH ADVISORS LP | 31 Mar, 2026 | 878,316 | 197,076 | 28.93% | $3,645,011.00 |
| BNP PARIBAS FINANCIAL MARKETS | 31 Mar, 2026 | 809,007 | -362,668 | -30.95% | $3,357,379.00 |
| Barclays Plc | 31 Mar, 2026 | 799,163 | 458,356 | 134.49% | $3,316,526.00 |